Peter M Andersen
Overview
Explore the profile of Peter M Andersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
228
Citations
9800
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Finsel J, Winroth I, Ciecwierska K, Helczyk O, Stenberg E, Haggstrom A, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Mar;
24(5-6):475-484.
PMID: 36994762
: Age and years of education are strong predictors of cognitive performance in several versions of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS) and cutoffs for the Swedish and...
22.
Adey B, Cooper-Knock J, Al Khleifat A, Fogh I, Van Damme P, Corcia P, et al.
Front Cell Neurosci
. 2023 Mar;
17:1112405.
PMID: 36937187
Caveolin-1 and Caveolin-2 (CAV1 and CAV2) are proteins associated with intercellular neurotrophic signalling. There is converging evidence that CAV1 and CAV2 (CAV1/2) genes have a role in amyotrophic lateral sclerosis...
23.
Dorst J, Weydt P, Brenner D, Witzel S, Kandler K, Huss A, et al.
EBioMedicine
. 2023 Mar;
90:104521.
PMID: 36917918
Background: The emergence of potentially effective new therapies for genetic forms of amyotrophic lateral sclerosis (ALS) necessitates the identification of biomarkers to facilitate early treatment, prior to the onset of...
24.
Dilliott A, Al Nasser A, Elnagheeb M, Fifita J, Henden L, Keseler I, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Mar;
24(5-6):420-435.
PMID: 36896705
: In 2021, the Clinical Genome Resource (ClinGen) amyotrophic lateral sclerosis (ALS) spectrum disorders Gene Curation Expert Panel (GCEP) was established to evaluate the strength of evidence for genes previously...
25.
Park J, Nordstrom U, Tsiakas K, Keskin I, Elpers C, Mannil M, et al.
Brain Commun
. 2023 Feb;
5(1):fcad017.
PMID: 36793789
Superoxide dismutase-1 is a ubiquitously expressed antioxidant enzyme. Mutations in can cause amyotrophic lateral sclerosis, probably via a toxic gain-of-function involving protein aggregation and prion-like mechanisms. Recently, homozygosity for loss-of-function...
26.
Yilmaz R, Grehl T, Eckrich L, Marschalkowski I, Weishaupt K, Valkadinov I, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Jan;
24(5-6):414-419.
PMID: 36650645
ALS patients with a negative family history (sporadic ALS, SALS) represent more than 90% of all ALS cases. In light of the gene-specific therapies that are currently in development for...
27.
Tazelaar G, Hop P, Seelen M, van Vugt J, van Rheenen W, Kool L, et al.
Neurobiol Aging
. 2022 Dec;
122:76-87.
PMID: 36521271
Amyotrophic lateral sclerosis is a heterogeneous, fatal neurodegenerative disease, characterized by motor neuron loss and in 50% of cases also by cognitive and/or behavioral changes. Mendelian forms of ALS comprise...
28.
Forsberg K, Graffmo K, Stenvall E, Tabikh N, Marklund S, Brannstrom T, et al.
Acta Neuropathol
. 2022 Nov;
145(1):13-28.
PMID: 36385230
Mutations in the gene encoding the ubiquitously expressed free radical scavenging enzyme superoxide dismutase-1 (SOD1) are found in 2-6% of amyotrophic lateral sclerosis patients. The most frequent SOD1 mutation worldwide...
29.
Nordstrom U, Lang L, Ekhtiari Bidhendi E, Zetterstrom P, Oliveberg M, Danielsson J, et al.
J Neurochem
. 2022 Nov;
164(1):77-93.
PMID: 36326589
Mutations in the human Superoxide dismutase 1 (hSOD1) gene are well-established cause of the motor neuron disease ALS. Patients and transgenic (Tg) ALS model mice carrying mutant variants develop hSOD1...
30.
Benatar M, Wuu J, Andersen P, Bucelli R, Andrews J, Otto M, et al.
Neurotherapeutics
. 2022 Sep;
19(5):1686.
PMID: 36175782
No abstract available.